FDA Inspection
Adare Pharmaceuticals, Inc.Adare Pharmaceuticals, Inc. – FDA Inspection, Feb 25, 2025
Record Details
This FDA Inspection record concerns Adare Pharmaceuticals, Inc., with an inspection on February 25, 2025, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · d31c7419-fc92-4be0-876c-798389f7db7b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1261982
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Adare Pharmaceuticals, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| January 25, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 11, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 19, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 14, 2014 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| November 16, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Adare Pharmaceuticals, Inc.
- FDA Inspection 1077858 - 2019-01-25
- FDA Inspection 1063146 - 2018-07-11
- FDA Inspection 1014959 - 2017-05-19
- FDA Inspection 904602 - 2014-11-14
- FDA Inspection 809244 - 2012-11-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.